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 BACKGROUND: Poor adherence to medication regimen leads to 
poor health outcomes, increased medical costs and increased death 
rate due to hypertension. The aim of this study was to evaluate 
baseline barriers to medication adherence among hypertensive 
patients in deprived rural areas.  
METHODS: A cross-sectional study was conducted on 238 
hypertensive patients living in deprived rural areas of Iran. Data 
were collected using a questionnaire consisting of demographic 
information, Morisky medication adherence scale and the barriers 
to medication adherence that were reliable and valid. 
RESULTS: The results of the study showed that medication 
adherence was significantly decreased and had a significant 
positive correlation with gender and economic status, while it had a 
negative correlation with age. Medication Adherence had a positive 
correlation with the duration of hypertension, while it had a 
negative correlation with the number of medications used and 
concurrently with other diseases. 
CONCLUSIONS: Based on the present study it can be concluded 
that enhanced knowledge about illness and treatment in rural 
communities is improves the medical adherence. Financial 
supports along with the reduced number of prescribed drugs are 
also found to be the determining factors in the medical adherence. 
KEYWORDS: Medication Adherence, Morisky scale, 




Hypertension is one of the most important risk factors for 
atherosclerosis, heart failure, stroke and renal failure. This disease 
usually does not have any symptoms, and little equipment is required 
for its detection that can be prevented, treated and controlled  with 
medicines (1). Control of blood pressure (BP) through 
pharmacological treatment leads to major benefits in preventing 
cardiovascular morbidity and mortality. Accordingly, medication 
adherence is an important factor in achieving blood 
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pressure control (2).  medication adherence is 
defined as: “the degree to which the person's 
behavior corresponds with the agreed 
recommendations from a health care provider” (3).  
Today, the National Association of American 
Nurses accepted the poor adherence to medication 
regimen as a nursing diagnosis (4). Unfortunately, 
poor adherence to medicines is prevalent (5). This 
fact leads to poor health outcomes and increased 
medical costs of drug-related morbidity (6). 
Several studies have been conducted on 
factors associated with medication nonadherence. 
Some studies have identified barriers to medication 
adherence and classified them as patient-related 
factors (e.g., disease-related knowledge, health 
literacy, and cognitive function) and drug-related 
factors (e.g., adverse effects and polypharmacy). 
Other factors, such as the patient-provider 
relationships, the cost of medications and regimen 
complexity have received less attention (7).  
Medication adherence is associated with high 
necessity and concern about treatment. In nursing 
practice, it is important to understand the specific 
barriers to adherence and engage patients in the 
implementation of strategies to improve adherence 
(8). 
Because barriers to medication adherence can 
vary widely  among  individuals and different 
cultures, many researchers have concluded that 
person-specific barriers should be identified 
through individualized screening techniques and 
interventions customized to address the needs of 
each individual (9). On the other hand, deprived 
rural areas often receive less attention due to low 
access to transport (10). Therefore, this study 
aimed to investigate the barriers to medication 
adherence among hypertensive patients in deprived 
rural areas in Iran. 
  
MATERIALS AND METHODS 
 
Study design: A descriptive cross-sectional study 
was conducted on 238 diagnosed hypertensive 
patients in five deprived rural areas of Iran.  
Sampling method: The convenience sampling 
method was used in this study and all patients in 
the 5 zones are available to researchers were 
included in the study. 
Socio-demographic characteristics: Demographic 
characteristics included age, gender, marital status, 
height and weight (for calculation of body mass 
index (BMI)) level of education, and few clinical 
information, such as diseases and disabilities, lipids 
level, duration of treatment, blood pressure and the 
total number of medications per day. 
Medication adherence scale: Medication 
adherence was measured using the structured self-
report 8-item Morisky Medication Adherence Scale 
(MMAS-8) (10). This adherence measure was 
designed to facilitate the identification of barriers 
to and behaviors associated with adherence to 
chronic medications. MMAS-8 scores range from 0 
to 8. The score of 8 is considered as high 
medication adherence, 6 to less than 8 as medium 
medication adherence, and less than 6 as low 
medication adherence. 
In previous validation studies, MMAS-U score 
less than 6 was associated with uncontrolled blood 
pressure. MMAS-8 score less than 6 has also been 
shown to be associated with poor antihypertensive 
medication pharmacy fill rates (11). The MMAS-8 
has been validated in outpatient settings with 
several groups of patients, which demonstrated 
good reliability (α=0.83) and validity in measuring 
adherence. It has been widely used in various  other 
studies to measure medication adherence (12). 
Because the MMAS-8 was quick and easy to 
complete, it was used in this study. A validated 
Persian version of the MMAS was available. 
Persian version of the MMAS has excellent 
stability (intraclass correlation = 0.95) and good 
acceptability of internal consistency (α = 0.80) 
(13). 
Medication adherence barriers scale: To assess 
self-reported medication barriers, we used a multi-
item scale that was developed by a researcher who 
used the results of previous studies (14). The multi-
item scale addresses common barriers, including 
having too much medication to take, forgetting 
whether medication was taken at a particular time 
and delaying taking pills to avoid side effects at an 
inconvenient time. Patients in the original measure 
were presented with 7 items and were asked 
whether the items were true or false. Patients were 
not advised to consider a specific medication; 
rather, the measure holistically assessed barriers. 
The items were as follows: (1) “I am not  taking 
medications to avoid having side effects”; (2) “I'm 
taking medicine only when I feel discomfort”; (3) 
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“I forgot my medications because of a lot of 
overwork”; (4) “I do not have the cost of providing 
medications”; (5) “There is no one to help me keep 
track of when to take my medication”; (6) “I 
believe that taking off and not taking medication 
did not have any effect on recovery”; and (7) “I 
have too much medication to take.” Response 
options included “definitely false,” “probably 
false,” “probably true,” and “definitely true” 
(coded 1 to 4). Summing responses to all items 
formed a summary score; higher scores correspond 
to more barriers. 
The scales used were valid and reliable. Their 
validity was proven by ten experts and their 
corrective comments were made. Cronbach's alpha 
reliabilities of the instrument were found  0.86 and 
0.89 for medication adherence and their barriers, 
respectively. 
Statistical analysis: All data were analyzed using 
SPSS version 21. Descriptive statistics, including 
means and proportions, were used to summarize 
the patients’ baseline socio-demographic and 
clinical characteristics. Simple linear regression 
was used to compare scores of medication 
treatment barriers for patients who were classified 
as nonadherent versus adherent.  
 
Ethical issues: After obtaining both the code of 
ethics (IR.SBMU.RETECH.REC.1395.605), and 
informed consent from the study participants, this 
study was conducted in the five deprived rural 
areas of Iran. Scale use permission was obtained 




Demographic characteristics and health status: 
Demographic characteristics of subjects are shown 
in Table 1. The participants' mean age was 57.40 
years (SD= 15.52), and 67.6% of the sample were 
females. The average number of antihypertensive 
medications used was 1.58 (SD 0.87), and 67.6% 
of the patients received only one antihypertensive 
drug. The average duration of antihypertensive 
drugs use was 2.14 years (SD= 0.73). Mean 
systolic and diastolic blood pressure in patients 
were 155.08 mm Hg (SD= 22.5) and 97.00 mm Hg 
(SD= 12.89), respectively. The mean score of the 
MMAS-8 was 6.56 (SD 1.56). Low adherence was 
seen in 18% of the patients, while medium and 
good adherence were observed in 43.6% and 
38.2%, respectively. As shown in Table 1, the 
average BMI was 23.4 (SD =6.73). 
Hypertensive patients' adherence to medication 
in deprived rural areas: The medication 
adherence rate in hypertensive patients in deprived 
rural areas was assessed using 8 items in 2-level 
spectrum. The results showed that the mean 
medication adherence was 0.69 so that most of the 
respondents had medium adherence (Table 2). 
Barriers to hypertensive patients' adherence to 
medication in rural and deprived area: The 
significance of barriers to medication adherence 
among hypertensive patients in rural deprived areas 
was measured by a 5-point Likert scale. Detailed 
results are given in Tables 3 and 4. As shown in 
Table 3, according to the respondents, in terms of 
barriers, “I do not have the cost of providing 
medications”, “There is nobody to help me keep 
track of when to take my medication”, and “I am 
taking medicine only when I feel discomfort” was 
very important. Barriers, “I am not taking 
medications to avoid having side effects (such as 
dizziness and headache)”, and “The number of my 
medications is high and I do not know whether 
they are taking it or not”, are of lower importance 
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Table 1: Demographic characteristics and health status. 
 
 
Variables Overall sample 
Male gender, % 67.6 female 
Mean age in years, SD 57.40 (15.52) 










Educational degree, % 
None 
Primary school  
Middle school  








BMI, SD 22.4 (9.7) 


























Mean n. of prescribed drugs (SD) 1.58 (0.87) 
Duration of antihypertensive drugs used (years) (SD) 2.14 (0.73) 
MMAS-8 adherence score. Mean score (SD)  
Low adherence (scores 1–5), %  
Medium adherence (scores 6–7), % 
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Table 2: Hypertensive patients' adherence to medication in deprived rural areas 
 
 
Medication adherence Mean Rank SD 
1. Do you sometimes forget to take your hypertensive pills? 0.70 0.46 
2. People sometimes miss taking their medications for reasons other than 
forgetting. Thinking over the past two weeks, were there any days when 
you did not take your hypertensive medicine? 
0.68 0.47 
3. Have you ever cut back or stopped taking your medication without 
telling your doctor, because you felt worse when you took it? 
0.64 0.48 
4. When you travel or leave home, do you sometimes forget to bring along 
your hypertensive medication? 
0.66 0.47 
5. Did you take your hypertensive medicine yesterday? 0.69 0.46 
6. When you feel like your hypertensive is under control, do you 
sometimes stop taking your medicine? 
0.65 0.48 
7. Taking medication every day is a real inconvenience for some people. 
Do you ever feel hassled about sticking to your hypertensive treatment 
plan? 
0.72 0.45 
8. How often do you have difficulty remembering to take all your 
medications? 
0.63 0.48 
*Description of the spectrum: Items 1 through 7 adherence1 and non-adherence 0. For item 8, if a patient 
chooses response ‘‘0”, the score is ‘‘1” and if they choose response ‘‘4”, the score is ‘‘0”. Responses ‘‘1, 2, 3” 
are respectively rated as ‘‘0.25, 0.50, 0.75” 
 
Table 3: Barriers to hypertensive patients' adherence to medication and Frequency of this barriers 
 
 
Barriers of medication adherence Mean 
Rank 












I do not have the cost of providing 
medications 
4.24 1.29 0.30 8 (3.4) 59 (24.8) 17 (7.1) 154 (64.7) 
there is no body to help me keep track 
of when to take my medication 
4.13 1.48 0.36 112 (47.1) 42 (17.6) 20 (8.4) 64 (26.9) 
I am taking medicine only when I felt 
discomfort 
4.03 1.28 0.32 66 (27.7) 24 (10.1) 46 (19.3) 102(42.9) 
I believe that drug intake does not 
affect my disease. 
3.49 1.38 0.40 94 (39.5) 27 (11.3) 39 (16.4) 78 (32.8) 
I forget to take medications because of 
my busy task. 
3.12 1.22 0.39 139 (58.4) 30 (12.6) 23 (9.7) 46 (19.3) 
I do not taking medications to avoid 
having side effects (such as dizziness 
and headache) 
2.30 1.54 0.67 
122 (51.3) 61 (25.6) 6 (2.5) 49 (20.6) 
the number of my medications is high 
and I do not know whether they are 
taking it or not 
2.29 1.45 0.64 
35 (14.7) 35 (14.7) 37 (15.5) 131 (55) 
*Description of the spectrum: Absolutely opposed 1....... Absolutely agree 5 
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The relationship between the degree of 
medication adherence and the socio-
demographic characteristics of the respondents: 
The Pearson Correlation test was used to examine 
the correlation between socio-demographic 
characteristics (such as age, gender, education 
level, marital status, income, employment) and the 
degree of medication adherence. Detailed results 
are presented in Table 4. 
As can be seen from Table 4, there was a 
significant positive relationship between the socio-
demographic characteristics (such as gender, 
educational level and monthly household income) 
and the degree of medication adherence, but a 
significant negative relationship existed between 
age and medication adherence. There was no 
statistically significant relationship between the 
variables of marital status and employment and 
medication adherence. 
 
Table 4: Correlation and Significant Level (the p value) of medication adherence and socio-demographic 
characteristics and treatment-related factors. 
 
 
Socio-demographic characteristics r P value 
Gender 0.41 <0.001 
Age -0.33 0.009 
Education level 0.69 <0.001 
Marital status 0.01 0.920 
Monthly household income 0.46 0.001 
Duration of drug used -0.27 0.031 
Systolic blood pressure 0.11 0.100 
Diastolic blood pressure 0.18 0.067 
treatment related Factors 
duration of hypertension 0.79 <0.001 
number of medications used -0.55 <0.001 
concurrently with other diseases -0.78 <0.001 
 
The relationship between medication adherence 
and treatment-related factors: Pearson correlation 
test was used to examine the association between the 
variables of treatment-related factors (such as 
duration of hypertension, the number of medications 
used and concurrently with other diseases) and the 
degree of medication adherence. Detailed results are 
presented in Table 4 above. As can be seen from 
Table 4, there was a significant positive relationship 
between the duration of hypertension and the degree 
of medication adherence. However, a significant 
negative relationship was found between the number 
of medications used and concurrently with other 
diseases and the degree of medication adherence. 
Demographic characteristics affecting the 
medication adherence: After entering all 
independent variables, a significant correlation was 
found between the regression relationship and the 
degree of medication adherence, which indicated that 
the level of education, economic status, and gender 
significantly associated with 53% of the total amount 
of changes in medication adherence (Tables 5 and 6). 
Therefore, other variables were not statistically 
significant.  
Treatment-related factors that affect medication 
adherence: After entering all the independent 
variables of treatment-related factors showing a 
significant correlation, the results showed that the 
duration of hypertension, the number of medications 
used and concurrently with other diseases 
significantly decreased to 76% of the total amount of 
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F p value 
Regression 24.33 3 8.11 91.15 <0.001 
Residual 20.81 234 0.08   
Total 45.14 237    
R= 0.73       R2=0.54          Adjusted R Square=0.53  
Treatment-related factors 
regression 34.55 3 11.51 254.36 <0.001 
residual 10.59 234 0.045   
Total 45.14 237    
R= 0.87         R2=0.76       Adjusted R Square=0.76 
 
Table 6: Regression coefficients of the variables affecting the medication adherence in step 3. 
 
Demographic characteristics  
 B Std.Error Beta t p value 
Constant 0.19 0.09 - 1.96 0.050 
level of education 0.21 0.02 0.55 10.92 <0.001 
economic status 0.08 0.02 0.19 3.92 <0.001 
gender -0.13 0.04 -0.15 -3.17 0.010 
treatment-related factors 
Constant 0.59 0.07 - 8.24 <0.001 
duration of hypertension 0.16 0.01 0.47 11.34 <0.001 
number of medications 
used 
-0.20 0.02 -0.42 -9.09 <0.001 
concurrently with other 
diseases 




Exploring barriers to medication adherence among 
hypertensive patients is important for several 
reasons. First of all, missing medical treatment can 
have serious consequences for health and result in 
increased morbidity and mortality. This study 
found a high percentage of medium adherence 
(43.6% of patients) and showed that socioeconomic 
factors and treatment-related factors were effective 
in medication adherence.   
The results of this study showed that the cost 
of drug and difficult access to medication are 
important barriers to medication adherence in 
deprived patients. These barriers can be remedied 
by changing health facilities in deprived areas and 
considering medicines subsidies for this people. 
In addition to receiving inadequate health 
services for patients living in deprived areas, they 
are even neglected in the field of research. We 
conducted this study because of our experiences of 
consecutive years of volunteering in deprived 
areas. Our study had a number of limitations. 
Firstly, it was difficult to reach all of hypertensive 
patients residing in deprived areas, and we 
randomly selected only 5 areas. The samples knew 
that the researchers were healthcare providers, so 
the results could be affected. Most of the samples 
did not have the necessary literacy to complete the 
questionnaires, and the researcher's native language 
was different from the patients'. All of the above 
limitations can cause bias. 
Generally, medication adherence varies from 
20 to 80 percent  in hypertensive patients (15). 
According to the World Health Organization, it 
may vary according to how this parameter is 
measured (16). Durand  reposted  that the most 
important reason for the difference in medication 
                 Ethiop J Health Sci.                           Vol. 30, No. 1                                     January 2020 
 
 




adherence (mean 31.2% and from 3.3 to 86.1%) 
was the use of different tools that self-expression 
tools had the highest degree (14). In this study, the 
percentage of medium medication adherence 
observed was higher  than that  in other studies (4, 
17), which might be attributed to many of factors in 
the context of community. 
This study showed that socioeconomic factors 
and treatment-related factors were effective in 
medication adherence. Several studies have been 
conducted on the causes of medication no 
adherence and  demonstrated   that these causes are 
patient-related factors (less information about 
health, less involvement in decision-making 
process) physician-related factors (multidrug 
regimens, communication barriers, side effects of 
medications, and a different multidisciplinary 
perspective), healthcare systems related factors 
(visit time constraints, care limitation, lack of 
health information technology) (18). In a review 
study, socio-economic factors, healthcare team-
related factors, context-dependent factors, 
treatment-related factors, and patient-related 
factors were effective in medication adherence 
(19). 
In this study, economic status was one of the 
factors affecting medication adherence that showed 
a significant positive relationship. A review of 
studies conducted in low- and middle-income 
countries showed that medication adherence among  
hypertensive patients was 36 to 65 percent,  and 
approximately 80% of the deaths which occurred  
in these countries were due to complications from 
hypertension(20), which are consistent with the 
findings of this study and the similarity of the field 
of study can be helpful in comparing the results. 
These cases reflect the modifiability of medication 
adherence in hypertensive patients and can be 
control many deaths related to hypertension.  In the 
present study, lack of financial resources was a 
major barrier to medication adherence. 
An interesting finding of  this study was that  
the lack of correlation between the status of 
employment and marital status of hypertensive 
patients and their medication adherence, while 
Lee’s  study showed that patients  who were non-
recruited and retired had more medication 
adherence (21). Kang's study also demonstrated 
that recruited people had a small chance of 
medication adherence (14). On the other hand, in 
most countries, non-recruited people had low 
medication adherence due to low access to 
healthcare systems and low financial resources. 
The duration of hypertension was a factor that 
showed a significant positive correlation with 
medication adherence. Several studies confirm that 
long history of hypertension is effective in 
medication adherence (14), and also there is a 
direct relationship between long history of 
hypertension, on average ten years, and medication 
adherence, which may be predictive (14). 
Medication adherence in a long history of 
hypertension can be due to high knowledge and 
experience about the situation, the proper 
relationship between the physician and the patient, 
and high confidence in the doctor's advice (19). 
Concurrency of hypertension with other 
diseases showed a significant negative correlation 
with their medication adherence, while Spike’s  
study showed that concurrency of other diseases 
with hypertension showed  a low correlation  that 
was significant with  medication adherence, and 
also the depression symptoms, hypertension belief 
and social support showed  no significant 
correlation with medication adherence (14). This 
difference in relationship, in addition to the type 
and duration of the disease, can also be related to 
the condition of the individual. 
In this study, there was a significant negative 
correlation between number of drugs consumed 
and medication adherence. Similar to our results, 
other studies also found that medication adherence 
in  patients taking two tablets per day was  higher 
than  that in those who took more than two tablets 
per day (14). Jankowska-Polanska study’s  showed 
that having a drug improves medication adherence 
(22). The reverse relationship between the number 
of treatments and medication adherence has been 
confirmed in numerous studies (14). 
 A review of  the qualitative studies showed 
that  in addition to the negative effects of barriers  
to medication adherence   in hypertensive patients, 
self-efficacy and beliefs of individuals have critical 
effect on medication adherence and should be 
discussed with hypertensive patients regarding 
their beliefs about treatment, complications, and 
the necessity of drug use and be modified opposing 
opinions (23). There was an inverse relationship 
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between perceived blood pressure control and 
medication adherence in the Patel study (24). 
Sometimes, medication nonadherence is due 
to limited understanding of the condition of the 
disease and treatment (25), which may help 
improve patients’  medication adherence by 
improving  patients’  understanding of their  
disease and treatment. The results of the present 
study also showed that in some cases, patients only 
used drugs when they felt uncomfortable, which 
might be due to their lack of familiarity with illness 
and treatment. However, in some studies, other 
methods, such as the use of software for the 
smartphone of patients can  improve their medical 
adherence (26). 
Our findings and also those from previous 
studies showed that improving patients’ 
understanding of their disease and treatment can 
improve medication adherence. In addition, to 
prevent the hypertensive complications, financial 
support for medicines could be useful. On the other 
hand, physicians can also reduce the cost of 
medication and increase medication adherence by 
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